Italy In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technology, By Application (Infectious Disease, Diabetes, Oncology/Cancer), By End-use, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5主要研究的细节
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3. Italy In Vitro Diagnostics (IVD) Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Growing geriatric population
3.2.1.2 Technological advancements
3.2.1.3 Increasing demand for PoC facilities
3.2.1.4 Growing prevalence of target diseases
3.2.2 Market restraint analysis
3.2.2.1 Higher cost of devices
3.2.2.2 Stringent regulatory and reimbursement policies
3.3 Penetration & Growth Prospect Mapping
3.4 Italy In Vitro Diagnostics (IVD): Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Italy Glucose Strip Market
3.7 Reagents Market by Application and End Use
Chapter 4. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Product, 2018 - 2030 (Revenue, USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Italy In Vitro Diagnostics (IVD) Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Reagents
4.5.2.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Technology 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Technology Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Italy In Vitro Diagnostics (IVD) Market, by Technology, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Immunoassay, by Product
5.5.1.1 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.2 Instruments
5.5.1.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.3 Reagents
5.5.1.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.4 Services
5.5.1.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Immunoassay, by Technology
5.5.2.1 Radioimmunoassay (RIA)
5.5.2.1.1 Radioimmunoassay (RIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2 Enzyme Immunoassays (EIA)/ELISA
5.5.2.2.1 Enzyme Immunoassays (EIA)/ELISA market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2.2 Chemiluminescence Immunoassays (CLIA)
5.5.2.2.2.1 Chemiluminescence Immunoassays (CLIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2.3 Fluorescence Immunoassays (FIA)
5.5.2.2.3.1 Fluorescence Immunoassays (FIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.4 Rapid Test
5.5.2.4.1 Rapid test market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.5 Others
5.5.2.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3 Hematology
5.5.3.1 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.2 Instruments
5.5.3.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.3 Reagents
5.5.3.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.4 Services
5.5.3.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4临床化学
5.5.4.1 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.2 Instruments
5.5.4.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.3 Reagents
5.5.4.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.4 Services
5.5.4.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5 Molecular Diagnostics/Genetics, by Product
5.5.5.1 Molecular diagnostics/genetics market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.2 Instruments
5.5.5.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.3 Reagents
5.5.5.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.4 Services
5.5.5.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6 Molecular Diagnostics/Genetics, by Technology
5.5.6.2 Polymerase Chain Reaction (PCR)
5.5.6.2.1 PCR market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.3 Sequencing
5.5.6.3.1 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.4 Hybridization
5.5.6.4.1 Hybridization market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.5 Chips & Microarrays
5.5.6.5.1 Chips & microarrays market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.6 TMA
5.5.6.6.1 TMA market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.7 INAAT
5.5.6.7.1 INAAT market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.8 Mass Spectrometry
5.5.6.8.1 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.9 Others
5.5.6.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7 Coagulation
5.5.7.1 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.2 Instruments
5.5.7.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.3 Reagents
5.5.7.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.4 Services
5.5.7.4.1服务米arket estimates and forecast, 2018 - 2030 (USD Million)
5.5.8 Microbiology
5.5.8.1 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.2 Instruments
5.5.8.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.3 Reagents
5.5.8.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.4 Services
5.5.8.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9 Others
5.5.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.2 Instruments
5.5.9.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.3 Reagents
5.5.9.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.4 Services
5.5.9.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Application, 2018 - 2030 (Revenue, USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Italy In Vitro Diagnostics (IVD) Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Infectious Disease
6.5.1.1 Infectious disease market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Diabetes
6.5.2.1 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3 Oncology/Cancer
6.5.3.1 Oncology/Cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4 Cardiology
6.5.4.1 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5 Nephrology
6.5.5.1 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6 Autoimmune Diseases
6.5.6.1 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7 Drug Testing
6.5.7.1 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
6.5.8 Others
6.5.8.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By End Use, 2018 - 2030 (Revenue, USD Million)
7.1 Definition and Scope
7.2 End Use Market Share Analysis, 2022 & 2030
7.3段仪表板
7.4 Italy In Vitro Diagnostics (IVD) Market, by End Use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Core Lab
7.5.1.1 Core lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2 SWA, by Location
7.5.1.2.1 SWA market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.2 Public Hospitals
7.5.1.2.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.3 Large Private Hospitals
7.5.1.2.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.4 Private
7.5.1.2.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3 SWA, by Type
7.5.1.3.1 Clinical Chemistry
7.5.1.3.1.1 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.2 Immunochemistry
7.5.1.2.2.1 Immunochemistry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3 Hematology
7.5.1.3.1 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.2 Public Hospitals
7.5.1.3.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.3 Large Private Hospitals
7.5.1.3.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.4 Private
7.5.1.3.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4 Coagulation
7.5.1.4.1 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.2 Public Hospitals
7.5.1.4.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.3 Large Private Hospitals
7.5.1.4.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.4 Private
7.5.1.4.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5 Urine Test
7.5.1.5.1 Urine Test market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.2 Public Hospitals
7.5.1.5.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.3 Large Private Hospitals
7.5.1.5.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.4 Private
7.5.1.5.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.6 Others
7.5.1.6.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Molecular Lab
7.5.2.1 Molecular Lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.2 HPV
7.5.2.2.1 HPV market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.3 Herpetics
7.5.2.3.1 Herpetics market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.4 Hepatitis
7.5.2.4.1 Hepatitis market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.5 HIV
7.5.2.5.1 HIV market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.6 NIPT
7.5.2.6.1 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.7 Others
7.5.2.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Pathology Lab
7.5.3.1 Pathology Lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2 Advanced Staining (Immunohistochemistry)
7.5.3.2.1 Advanced staining (Immunohistochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.2 Public Hospitals
7.5.3.2.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.3 Large Private Hospitals
7.5.3.2.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.4 Private
7.5.3.2.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3 Primary Staining (Hematoxylin Eosin and Histochemistry)
7.5.3.3.1 Primary staining (Hematoxylin Eosin and Histochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.2 Public Hospitals
7.5.3.3.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.3 Large Private Hospitals
7.5.3.3.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.4 Private
7.5.3.3.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4 Blood Banks
7.5.4.1 Blood Banks market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.2 SWA
7.5.4.2.1 SWA market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.3 Molecular Test
7.5.4.3.1 Molecular test market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4 Point of Care (PoC)
7.5.4.1 Point of Care (PoC) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.2 Clinics
7.5.4.2.1 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.3 Hospitals
7.5.4.3.1 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.4 Retail
7.5.4.4.1 Retail market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.5 Military premises
7.5.4.5.1 Military premises market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.6 Airports
7.5.4.6.1 Airports market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.7 Others
7.5.4.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5 Others
7.5.5.1其他市场估计和预测,2018年- 2030 (USD Million)
7.5.5.2 NGS
7.5.5.2.1 NGS market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5.3 Mass Spectrometry
7.5.5.3.1 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5.4 Others
7.5.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Region, 2018 - 2030 (Revenue, USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4区域3月ket Snapshot
8.5 SWOT Analysis
8.5.1 Italy
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
8.6.1 Italy
8.6.1.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Italy In Vitro Diagnostics (IVD) Market - Competitive Analysis
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4. Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 F. Hoffmann-La Roche Ltd.
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Abbott
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 bioMerieux SA
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Danaher
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4战略举措
9.6.5 QIAGEN
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 BD
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 Sysmex Corporation
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 DiaSorin公司。
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 The Menarini Group
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4战略initiatives
9.6.10 SENTINEL CH. SpA
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Quidel Corporation.
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.101.4 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Italy In Vitro Diagnostics (IVD) Market, By Region, 2018 - 2030 (USD Million)
Table 5 Italy In Vitro Diagnostics (IVD) Market, By Product, 2018 - 2030 (USD Million)
Table 6 Italy In Vitro Diagnostics (IVD) Market, By Technology, 2018 - 2030 (USD Million)
Table 7 Italy In Vitro Diagnostics (IVD) Market, By Application, 2018 - 2030 (USD Million)
Table 8 Italy In Vitro Diagnostics (IVD) Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Italy In Vitro Diagnostics (IVD) market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Italy In Vitro Diagnostics (IVD) market: Product movement analysis
Fig. 17 Italy In Vitro Diagnostics (IVD) market: Product segment dashboard
Fig. 18 Italy In Vitro Diagnostics (IVD) market: Product outlook: Key takeaways
Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Services medication market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Italy In Vitro Diagnostics (IVD) market: Technology movement analysis
Fig. 23 Italy In Vitro Diagnostics (IVD) market: Technology segment dashboard
Fig. 24 Italy In Vitro Diagnostics (IVD) market Technology outlook: Key takeaways
Fig. 25 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Radioimmunoassay (RIA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 ELISA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Chemiluminescence Immunoassay (CLIA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Fluorescence Immunoassays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Rapid Test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Clinical Chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 PCR market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Hybridization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Chips & Microarrays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 TMA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 INNAT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Mass Spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Italy In Vitro Diagnostics (IVD) market: Application movement analysis
Fig. 46 Italy In Vitro Diagnostics (IVD) market: Application segment dashboard
Fig. 47 Italy In Vitro Diagnostics (IVD) market Application outlook: Key takeaways
Fig. 48 Infectious Disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Oncology/Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Autoimmune Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Drug Testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Italy In Vitro Diagnostics (IVD) market: End Use movement analysis
Fig. 57 Italy In Vitro Diagnostics (IVD) market: End Use segment dashboard
Fig. 58 Italy In Vitro Diagnostics (IVD) market End Use outlook: Key takeaways
Fig. 59 Core Lab market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 SWA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Immunochemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Urine test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Molecular Lab market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 HPV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Herpetics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Hepatitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 HIV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Pathology lab market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Advanced staining (Immunohistochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Primary staining (Hematoxylin Eosin and Histochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Blood banks market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 SWA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Molecular test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 PoC market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 NGS market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Regional outlook, 2022 & 2030
Fig. 86 Regional market dashboard
Fig. 87 Regional market place: Key takeaways
Fig. 88 Italy, SWOT
Fig. 89 Italy
Fig. 90 Italy in vitro diagnostics (IVD) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Ansoff Matrix
Fig. 92 Heat map analysis
Fig. 93 Market differentiators